Avoid Errors With the New HIV Med, Dovato

Dovato (doh-VAH-toh) will be a new complete HIV regimen with TWO meds in one pill...for treatment-naive patients.

It combines the integrase inhibitor dolutegravir with the nucleoside reverse transcriptase inhibitor lamivudine.

Dovato will try to compete with THREE-med, one-pill combos, such as Biktarvy (bictegravir/emtricitabine/tenofovir).

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote